Kenton Wong awarded IMechE Prize and joins Embed Biotech as Product Development Engineer

Embed Biotech is proud to announce that Kenton Wong has been awarded the Institution of Mechanical Engineers Prize for his outstanding Master’s project completed with Embed Biotech.

Embed Biotech is proud to announce that Kenton Wong has been awarded the Institution of Mechanical Engineers (IMechE) Prize for his outstanding Master’s project completed in collaboration with Embed Biotech. Following the award, Kenton has now joined the company as a Product Development Engineer.

Founded in 1847, the Institution of Mechanical Engineers’ annual IMechE Prize is awarded to an Imperial student who completes an exceptional research, development, or design project in Mechanical Engineering. Kenton won this year’s award in recognition of his work building a platform for investigating how cells respond to biophysical stimuli.

“Kenton’s work really stands out for the technical rigour and innovation shown across a complex project, which combined both engineering and experimental biology.” said Richard van Arkel, Founder and Chief Scientific Officer. “We are delighted to welcome him to the team as we continue advancing our technology towards clinical application.”

Kenton’s transition from award-winning student collaborator to Product Development Engineer reflects Embed Biotech’s continued connection to academic research and emerging engineering talent.

“I’m excited to be joining Embed Biotech at such an important stage in its journey,” said Kenton Wong. “Having seen the cellular response first-hand during my Master’s project, I believe this technology has the potential to make a real difference and I look forward to helping bring it to the world.”

About Embed Biotech
Embed Biotech is a private company pioneering bioelectronic medicine in orthopaedics — a paradigm shift in healing driven by targeted biophysical signals that activate the body’s natural regenerative response at the cellular level.

Read more


May 21, 2026
News
Embed Biotech today announced the appointment of Simon Dawkins as Special Advisor, Commercial Strategy and Market Access, effective 5 January 2026.
October 21, 2025
News
Embed Biotech is excited to announce the appointment of Laura Whitsitt as a Non-Executive Director, effective 15 October 2025.